Entries by Ayal Ronen
Available Online: Non-Dilutive Funding Opportunities for Pre-Clinical Reseach Webinar
Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences. Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences, and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private […]
Congress Saves NIH Budget!
Congress: NIH Budget Will Not Be Cut Congress Inks Spending Deal That Jettisons Trump Priorities – Bloomberg News, May 1, 2017 U.S. House and Senate negotiators reached a tentative bipartisan deal on a $1.1 trillion spending bill that largely tracks with Democratic priorities and rejects most of President Donald Trump’s wish list. Overall, the compromise […]
Available Online: Non-Dilutive Funding Opportunities for Cancer R&D Webinar
NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle with an emphasis on pre-clinical work, and may cover clinical stage activities as well. In this webinar, we discuss key cancer related opportunities, mainly within the National Cancer Institute (NCI), that […]
Powered by CARB-X
Tyler Merkeley, CARB-X co-founder and program director for ASPR’s Biomedical Advanced Research and Development Authority, describes the drivers and next steps in creating a diverse portfolio Powered by CARB-X, one of the world’s largest public-private partnerships dedicated to accelerating development of innovative antibacterial drugs, diagnostics, and devices.
Investment for Advanced Therapies – May 3, 2017
FreeMind is proud to support the upcoming Investment for Advanced Therapies event! When: May 3, 2017 Where: London, UK Investment for Advanced Therapies will be the C-Level meeting place for heavyweight investors, analysts, biotechs, venture partners and industry experts who are driving the industry forward. Don’t miss your chance to shape the future and put your […]
MedFIT – Fostering Innovation in medTech
FreeMind is pleased to support the upcoming MedFIT event! Where: Grenoble, France When: June 28-29, 2017 A 360° approach to build innovation partnerships, source licensing deals and accelerate market access in medtech. Organised by Eurasanté and the NHL Cluster, with the support of Medicalps and Alsace BioValley, the 1st edition of MedFIT will gather […]
Available Online: Biodefense and Infectious Diseases Funding Opportunities Webinar
The National Institute of Allergies and Infectious Diseases (NIAID) awards close to $6,000,000,000 annually. Taking into account activities by DTRA, DARPA, US Army, BARDA, etc., this is a funding force no one in the field can afford to ignore. In this webinar, we introduce you to Biodefense and Infectious Diseases sources of funding such as […]
BioTrinity 2017
The FreeMind Group is proud to support the upcoming BioTrinity conference! Where: London, UK When: May 8-10, 2017 BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK. Now in its 11th year, the aim of BioTrinity is simple – create an ideal networking and partnering platform for life science companies […]
Available Online: Introduction to SBIR and STTR Funding Opportunities Webinar
Opening FreeMind’s 2017 webinar series is an introduction to the SBIR and STTR mechanisms which account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics. SBIR/STTRs differ from traditional NIH mechanisms in that they […]